CLOBAZAM

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 72205-048
  • Package NDC 72205-048-91
  • Application number ANDA213404
  • SPL ID 3c8a899d-7c67-43d5-9428-0c0d0f9583de
  • SPL set ID cf5bb37f-5386-47d3-8cec-d48253d359f6
  • UNII 2MRO291B4U
  • RxCUI 199450
  • RxCUI 246172

What the source publishes

Labeler
Novadoz Pharmaceuticals LLC
Active ingredients
CLOBAZAM
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:72205-048_3c8a899d-7c67-43d5-9428-0c0d0f9583de
{
  "name": "CLOBAZAM",
  "splId": "3c8a899d-7c67-43d5-9428-0c0d0f9583de",
  "labels": [
    {
      "setId": "cf5bb37f-5386-47d3-8cec-d48253d359f6",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf5bb37f-5386-47d3-8cec-d48253d359f6",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf5bb37f-5386-47d3-8cec-d48253d359f6"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Novadoz Pharmaceuticals LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE in 1 CARTON (72205-048-91)  / 100 TABLET in 1 BOTTLE",
      "package_ndc": "72205-048-91",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220610"
    }
  ],
  "productId": "72205-048_3c8a899d-7c67-43d5-9428-0c0d0f9583de",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "72205-048",
  "deaSchedule": "CIV",
  "genericName": "CLOBAZAM",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CLOBAZAM",
      "strength": "20 mg/1"
    }
  ],
  "applicationNumber": "ANDA213404",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20220610",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175694",
      "M0002356",
      "N0000182137",
      "N0000185506"
    ],
    "upc": [
      "0372205047914",
      "0372205048911"
    ],
    "unii": [
      "2MRO291B4U"
    ],
    "rxcui": [
      "199450",
      "246172"
    ],
    "spl_set_id": [
      "cf5bb37f-5386-47d3-8cec-d48253d359f6"
    ],
    "pharm_class_cs": [
      "Benzodiazepines [CS]"
    ],
    "pharm_class_epc": [
      "Benzodiazepine [EPC]"
    ],
    "pharm_class_moa": [
      "Cytochrome P450 2D6 Inhibitors [MoA]",
      "Cytochrome P450 3A4 Inducers [MoA]"
    ],
    "manufacturer_name": [
      "Novadoz Pharmaceuticals LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:72205-048_3c8a899d-7c67-43d5-9428-0c0d0f9583de"